Stanley J. Hollenbach

A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa

Genmin Lu, Francis DeGuzman, Stanley J. Hollenbach et al. · Nature Medicine · 2013 · 697 citations

Medicine, Hematology, Pharmacology +16

Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.

Nathalie A. Lokker, Carol M. Sullivan, Stanley J. Hollenbach et al. · PubMed · 2002 · 436 citations

Medicine, Cell Biology, Oncology +17

CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)

Louise Kelly, Jin‐Chen Yu, Christina Boulton et al. · Cancer Cell · 2002 · 307 citations · Full text

Medicine, Oncology, Pharmacology +10

Specific Inhibition of Spleen Tyrosine Kinase Suppresses Leukocyte Immune Function and Inflammation in Animal Models of Rheumatoid Arthritis

Greg Coffey, Francis DeGuzman, Mayuko Inagaki et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 117 citations

Medicine, Immunology, Pharmacology +17

Identification of Orally Active, Potent, and Selective 4-Piperazinylquinazolines as Antagonists of the Platelet-Derived Growth Factor Receptor Tyrosine Kinase Family

Anjali Pandey, Deborah L. Volkots, J. Seroogy et al. · Journal of Medicinal Chemistry · 2002 · 114 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15